Top 4 Canadian Biotech Stocks (Updated January 2025)
Source: Investing News Network
2025-04-23 12:12:05 ET
Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector is home to companies pursuing cutting-edge therapies and medical technologies.
According to Grandview Research , the global biotech market is expected to grow at a compound annual growth rate of 13.96 percent between 2024 and 2030 to reach a value of US$3.08 trillion.
Here the Investing News Network profiles the four best-performing Canadian biotech stocks based on year-on-year gains. Data on these companies was collected on January 14, 2025, using TradingView's stock screener .
For further details see:
Top 4 Canadian Biotech Stocks (Updated January 2025)
Cardiol Therapeutics Inc.
NASDAQ: CRDL:CC
CRDL:CC Trading
4.05% G/L:
$1.80 Last:
82,631 Volume:
$1.73 Open:
CRDL:CC Latest News
February 25, 2026 07:27:00 am
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference
February 10, 2026 07:27:00 am
Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure
